FDA – Page 68 – Pharma.Tips

Audit trail gaps identified during system upgrades – data integrity risk and remediation

Addressing Audit Trail Gaps Discovered During System Upgrades: A Comprehensive Investigation In the constantly evolving landscape of pharmaceutical manufacturing, maintaining data integrity is paramount, especially during system upgrades. Audit trail…

Inventory control failure during inspection – regulatory inspection outcome

Investigating Inventory Control Failures During Regulatory Inspections Inventory control failures can have far-reaching implications in pharmaceutical manufacturing, potentially leading to non-compliance during regulatory inspections, product shortages, or compromised product quality.…

Data backup and restore failure during validation lifecycle – inspection evidence pack preparation

Addressing Data Backup and Restore Failures During the Validation Lifecycle In the highly regulated pharmaceutical industry, maintaining data integrity throughout the validation lifecycle is crucial. Data backup and restore failures…

Inventory control failure during audit – CAPA and system remediation

Understanding Inventory Control Failures During Audits: A Comprehensive Investigation Guide In pharmaceutical manufacturing, inventory control is a critical component ensuring compliance with Good Manufacturing Practices (GMP) and regulatory requirements. However,…

User account governance failures during system upgrades – inspection evidence pack preparation

“`html Investigating User Account Governance Failures During System Upgrades in Pharma Operations In the pharmaceutical sector, the integrity of user account governance is crucial, especially during system upgrades. Failures in…

Transport qualification gaps during audit – how to prevent repeat excursions

Addressing Transport Qualification Gaps Identified During Audits Transport qualification gaps can significantly compromise the integrity of pharmaceutical products, leading to audits revealing serious compliance issues. Whether due to temperature excursions,…

User account governance failures during system operation – preventing repeat CSV observations

Addressing User Account Governance Failures During System Operation: An Investigative Approach In the pharmaceutical industry, maintaining robust user account governance during system operation is crucial for ensuring compliance with regulatory…

Distribution temperature breach during inspection – how to prevent repeat excursions

Understanding and Mitigating Distribution Temperature Breaches During Inspections Distribution temperature breaches can pose significant challenges in pharmaceutical manufacturing and supply chain logistics, especially during regulatory inspections. Such excursions not only…

Interface validation gaps during inspection walkthrough – CAPA and revalidation strategy

“`html Addressing Gaps in Interface Validation During Inspection Walkthroughs: A CAPA and Revalidation Framework In today’s highly regulated pharmaceutical environment, interface validation gaps can expose organizations to significant compliance risks,…

Tag: FDA